The news that Alasdair Haynes is stepping down as chief executive of Aquis Exchange was met with a mixture of surprise, disappointment and understanding.Read More
You might also be interested in reading Fractyl signals accelerated enrollment for REMAIN-1 study while advancing Rejuva clinical milestones.